Cancer Tech Pitch Deck: ViroMissile
Destroying cancer with a one-shot cure.
ViroMissile is developing the next generation of oncolytic viruses for cancer diagnosis and treatment. They have created the first-ever stealth oncolytic virus that survives well in blood and is resistant to being cleared by NK and T-cells.
I had the privilege of working with ViroMissile to create the cutting-edge cancer tech company's website (live at viromissile.com) and Series A investor pitch deck.
* * *
Like this page? Create your own showcase like this!
Download the templates below that were featured in this portfolio page!
↓ ↓ ↓
SLIDES SHOWCASE MOCKUP (.PSD)
